| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.05. | Advanced Biomed Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.05. | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.04. | Advanced Biomed sichert sich unbesicherten Kredit in Höhe von 600.000 US-Dollar | 2 | Investing.com Deutsch | ||
| 14.04. | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| ADVANCED BIOMED Aktie jetzt für 0€ handeln | |||||
| 07.04. | Morning Market Movers: Advanced Biomed, Sky Quarry, Focus Universal, Kiora Pharmaceuticals See Big Swings | 723 | AFX News | WOONSOCKET (dpa-AFX) - At 8:40 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 03.04. | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.03. | Advanced Biomed Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.02. | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance | 1 | Investing.com | ||
| 18.02. | Advanced Biomed Inc. Announces 1 for 20 Share Consolidation | 202 | GlobeNewswire (Europe) | Tainan City, Taiwan, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the "Company" or "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative... ► Artikel lesen | |
| 13.02. | Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery | 2 | GlobeNewswire (USA) | ||
| 02.02. | Advanced Biomed Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.01. | Advanced Biomed Inc. regelt Schuldenrückzahlung von Tochtergesellschaft in Nachtragsvereinbarung | 1 | Investing.com Deutsch | ||
| 21.01. | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.12.25 | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.12.25 | Advanced Biomed-Aktie steigt nach Verkauf von Hongkong-Tochter | 1 | Investing.com Deutsch | ||
| 30.12.25 | Advanced Biomed veräußert Hongkong-Tochter für 23.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 30.12.25 | Advanced Biomed sells Hong Kong subsidiary for $23,000 | 1 | Investing.com | ||
| 30.12.25 | Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary | 408 | GlobeNewswire (Europe) | Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the "Company", "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,850 | +6,01 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| ORGANON | 11,590 | -0,04 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| CO-DIAGNOSTICS | 5,725 | +1,69 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| SENSEONICS | 5,850 | +0,86 % | Senseonics Holdings, Inc.: Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems | ||
| VIRIDIAN THERAPEUTICS | 13,600 | 0,00 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| INSPIRE MEDICAL SYSTEMS | 35,600 | -0,56 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| VYOME | 2,170 | +0,46 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| EMBECTA | 2,960 | +0,78 % | Embecta Corp.: embecta to Participate in Investor Events | ||
| PROCEPT BIOROBOTICS | 27,850 | +0,07 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 36,870 | 0,00 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 21,960 | -0,27 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 3,860 | -1,03 % | Der durch STRC besicherte Stablecoin von Apyx erleidet eine kurze Entkopplung. Das Protokoll bezeichnet dies als Funktion, nicht als Fehler | ||
| GLAUKOS | 102,00 | -6,42 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,637 | 0,00 % | Lexaria Bioscience Corp.: Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program | KELOWNA, BC / ACCESS Newswire / June 3, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, announces that it is attending... ► Artikel lesen | |
| PICARD MEDICAL | 0,260 | +0,15 % | Artificial Heart Maker Picard Medical's Stock Surges 15% After Hours: Here's What's Going On With PMI |